71 related articles for article (PubMed ID: 863376)
1. Regional release of glucagon-like immunoreactivity from the intestine of the cat.
Frame CM
Horm Metab Res; 1977 Mar; 9(2):117-20. PubMed ID: 863376
[TBL] [Abstract][Full Text] [Related]
2. The contribution of the distal gastrointestinal tract to glucagon-like immunoreactivity secretion in the rat.
Frame CM
Proc Soc Exp Biol Med; 1976 Sep; 152(4):667-70. PubMed ID: 967899
[TBL] [Abstract][Full Text] [Related]
3. Anomeric specificity in the response of gut glucagon-like immunoreactive materials to glucose.
Matsuyama T; Tanaka R; Shima K; Tarui S
Horm Metab Res; 1979 Mar; 11(3):214-6. PubMed ID: 447202
[TBL] [Abstract][Full Text] [Related]
4. Purification of canine gut glucagon-like immunoreactivity (GLI) and its insulin releasing activity.
Ohneda A; Horigome K; Kai Y; Itabashi H; Ishii S; Yamagata S
Horm Metab Res; 1976 May; 8(3):170-4. PubMed ID: 939462
[TBL] [Abstract][Full Text] [Related]
5. The use of perfused rat intestine to characterise the glucagon-like immunoreactivity released into serosal secretions following stimulation by glucose.
O'Connor FA; Conlon JM; Buchanan KD; Murphy RF
Horm Metab Res; 1979 Jan; 11(1):19-23. PubMed ID: 428905
[TBL] [Abstract][Full Text] [Related]
6. The effect of calcium and other salts upon the release of glucagon-like immunoreactivity from the gut.
Böttger I; Faloona GR; Unger RH
J Clin Invest; 1972 Apr; 51(4):831-6. PubMed ID: 5014613
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose.
Unger RH; Ohneda A; Valverde I; Eisentraut AM; Exton J
J Clin Invest; 1968 Jan; 47(1):48-65. PubMed ID: 5638120
[TBL] [Abstract][Full Text] [Related]
8. Glucagon and the gut.
Buchanan KD; Zandomeneghi R; Murphy RF; Teale JD
Gut; 1971 Oct; 12(10):861. PubMed ID: 5123283
[No Abstract] [Full Text] [Related]
9. Chromatographic pattern of gut glucagon-like immunoreactivity (GLI) in plasma before and during glucose absorption.
Valverde I; Ghiglione M; Matesanz R; Casado S
Horm Metab Res; 1979 May; 11(5):343-6. PubMed ID: 478429
[TBL] [Abstract][Full Text] [Related]
10. Release of somatostatin-like immunoreactivity from the lower gut.
Rouiller D; Schusdziarra V; Conlon JM; Harris V; Unger RH
Gastroenterology; 1979 Oct; 77(4 Pt 1):700-3. PubMed ID: 467926
[TBL] [Abstract][Full Text] [Related]
11. Fetal rat intestinal cells in monolayer culture: a new in vitro system to study the glucagon-like immunoreactive peptides.
Brubaker PL; Vranic M
Endocrinology; 1987 May; 120(5):1976-85. PubMed ID: 3552626
[TBL] [Abstract][Full Text] [Related]
12. Elevation of plasma glucagon-like immunoreactivity (GLI) in patients with liver cirrhosis.
Watanabe A; Hashimoto M; Higashi T; Kobayashi M; Nakatsukasa H; Yamauchi Y; Watanabe M; Fujiwara M; Nagashima H
J Med; 1986; 17(2):95-108. PubMed ID: 3473162
[TBL] [Abstract][Full Text] [Related]
13. Effect of insulin on the response of gut glucagon-like immunoreactivity (GLI) to oral glucose and food ingestion in the goose.
Karmann H; Mialhe P
Horm Metab Res; 1987 Feb; 19(2):47-52. PubMed ID: 3549502
[TBL] [Abstract][Full Text] [Related]
14. Early regional expression and secretion of peptide YY and enteroglucagon after massive resection of small bowel.
Bilchik AJ; Hines OJ; Adrian TE; Skotzko MJ; McFadden DW; Zinner MJ; Ashley SW
J Am Coll Surg; 1995 Apr; 180(4):417-26. PubMed ID: 7719545
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical demonstration of glucagon- and GLI-containing cells in the canine gut and pancreas.
Ito S; Kobayashi S
Arch Histol Jpn; 1976 Jul; 39(3):193-202. PubMed ID: 788674
[TBL] [Abstract][Full Text] [Related]
16. [Absorption of isosorbide dinitrate in guinea-pig intestine and in the colon of sheep (author's transl)].
Schmidt A; von Engelhardt W
Arzneimittelforschung; 1982; 32(2):106-10. PubMed ID: 6802143
[TBL] [Abstract][Full Text] [Related]
17. Peculiar glucagon processing in the intestine is the genesis of the paradoxical rise of serum pancreatic glucagon in patients after total pancreatectomy.
Tanjoh K; Tomita R; Fukuzawa M; Hayashi N
Hepatogastroenterology; 2003; 50(50):535-40. PubMed ID: 12749267
[TBL] [Abstract][Full Text] [Related]
18. Adaptation of the Na+/glucose cotransporter following intestinal resection.
Hines OJ; Bilchik AJ; Zinner MJ; Skotzko MJ; Moser AJ; McFadden DW; Ashley SW
J Surg Res; 1994 Jul; 57(1):22-7. PubMed ID: 8041142
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic glucagon-like immunoreactivity in a pancreatectomized patient.
Botha JL; Vinik AI; Child PT; Paul M; Jackson WP
Horm Metab Res; 1977 May; 9(3):199-205. PubMed ID: 885471
[TBL] [Abstract][Full Text] [Related]
20. Enzymatic degradation of glucagon and glucagon-like immunoreactivity (GLI).
Bansal DD; Carlin AJ; Irvine GB; McKibben B; Murphy RF; Elmore DT; Buchanan KD
Indian J Biochem Biophys; 1986 Apr; 23(2):123-5. PubMed ID: 2945774
[No Abstract] [Full Text] [Related]
[Next] [New Search]
